Markets.com Logo

GLAXO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2782.2338$
  • Previous Close
    2797.8359$
  • 52 Week Change
    1619.42$
  • Day Range
    -15.60$
  • 52 Week High/Low
    1896.2767$ - 3515.7$
  • Dividend Per Share
    0
  • Market cap
    471 712 M$
  • EPS
    9.89
  • Beta
    0.064
  • Volume
    --

About

GLAXO.NSE refers to the stock of GlaxoSmithKline Pharmaceuticals Limited listed on the National Stock Exchange of India (NSE). It represents a share in the ownership of this pharmaceutical company, allowing investors to participate in its financial performance. The company is a subsidiary of GlaxoSmithKline plc, a global research-based pharmaceutical and healthcare company.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Government Regulations: Changes in drug pricing policies and regulatory approvals can significantly impact GlaxoSmithKline's (GSK) revenue and profitability.

Clinical Trial Outcomes: Positive results from clinical trials for new drugs typically boost investor confidence, while negative results can lead to stock declines.

Economic Conditions: Overall economic growth or recession in key markets can influence healthcare spending and demand for GSK's products.

Competition: The emergence of new competitors or generic versions of existing drugs can erode GSK's market share and profitability.

Patent Expiry: When patents expire on key drugs, generic versions become available, leading to lower sales and reduced revenue for GSK.

Mergers and Acquisitions: M&A activity in the pharmaceutical sector can affect investor sentiment and the perceived value of GSK's stock.

Global Health Events: Pandemics or outbreaks of infectious diseases can impact demand for vaccines and antiviral medications.

Company-Specific News: Announcements about new product launches, earnings reports, or strategic initiatives can influence investor behavior.

Investor Sentiment: General market optimism or pessimism can affect trading volumes and stock valuations across the board.

Currency Fluctuations: Changes in exchange rates can impact GSK's international earnings and overall financial performance.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--